Truist Financial’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-11,307
Closed -$104K – 2594
2024
Q4
$104K Sell
11,307
-1,709
-13% -$16K ﹤0.01% 2464
2024
Q3
$126K Sell
13,016
-1,825
-12% -$19.1K ﹤0.01% 2403
2024
Q2
$121K Sell
14,841
-628
-4% -$4.86K ﹤0.01% 2571
2024
Q1
$125K Sell
15,469
-2,121
-12% -$15K ﹤0.01% 2538
2023
Q4
$96.6K Sell
17,590
-11,978
-41% -$63.3K ﹤0.01% 2568
2023
Q3
$154K Sell
29,568
-1,224
-4% -$8.7K ﹤0.01% 2481
2023
Q2
$356K Sell
30,792
-1,104
-3% -$13K ﹤0.01% 2156
2023
Q1
$398K Buy
31,896
+1,464
+5% +$28K ﹤0.01% 2112
2022
Q4
$600K Buy
30,432
+6,232
+26% +$134K ﹤0.01% 1834
2022
Q3
$587K Buy
24,200
+11,617
+92% +$321K ﹤0.01% 1742
2022
Q2
$304K Sell
12,583
-763
-6% -$20.3K ﹤0.01% 2207
2022
Q1
$433K Buy
+13,346
New +$420K ﹤0.01% 2085
2021
Q3
– Sell
-6,646
Closed -$433K – 2762
2021
Q2
$433K Buy
+6,646
New +$421K ﹤0.01% 2155

Other funds holding INGN

Truist Financial's INGN Position: Q1 2025 in Review

Truist Financial sold out of Inogen (INGN) in Q1 2025, closing a stake of 11,307 shares — an estimated $104K sold.

Truist Financial first reported a position in INGN in Q2 2021 and held it in 13 quarters. The position peaked at $600K in Q4 2022. 128 funds tracked by Wall St. Rank hold INGN as of Q1 2025.

  • Truist Financial reported no remaining Inogen position as of Q1 2025 after selling out during the quarter.
  • Truist Financial sold 11,307 Inogen shares in Q1 2025, an estimated $104K.
  • Truist Financial first reported a position in Inogen in Q2 2021 and held it in 13 quarters.
  • Truist Financial's Inogen position peaked at $600K in Q4 2022.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.